Lesaffre acquires a majority interest in US bioscience-based Envera

20 Nov 2017 --- As part of its ongoing expansion strategy in nutrition and health, Lesaffre has announced the acquisition of a majority interest in Envera, an innovative US bioscience-based company. Founded in 2004 by Michael L. Matheny, a long-time microbiologist entrepreneur and executive, Envera is a full solution provider in the field of microbiology. Based in West Chester, Pennsylvania, with experienced researchers, Envera develops specific microbial-based products for a range of applications. 

With this transaction, Lesaffre will enhance its presence and product offering in the fast-growing nutritional ingredients and health sector. In July 2017, Lesaffre announced an investment in Intralytix, another US biotechnology company and leader in bacteriophage technology. 

Antoine Baule, Lesaffre’s Chief Executive Officer says: “Lesaffre welcomes this acquisition which is entirely in line with its' strategic development objectives. We are pleased to contribute to Envera’s development and to build upon the skills and expertise of the team in place. The specific technology and the strains collection developed by the company will provide a substantial addition to our current portfolio.” 

Baule spoke to FoodIngredientsFirst: “Lesaffre will propose to its customers in nutrition and health solutions based on Envera’s sporulating bacteria, that will be great additions to Lesaffre current portfolio.”

“Envera’s current offering will be marketed by Lesaffre’s marketing and global sales network, and be available to customers much faster,” Baule explains. 
 
“A lot of synergies will be developed between the two companies especially in R&D, generating new products and accelerating growth, resulting if needed in new jobs creation.”

Paolo Rossi, President of Lesaffre’s Nutrition and Health activity, adds: “Envera’s impressive range of bacteria strains and products will enable us to widen our offering of microorganisms to our customers, especially in the field of human, animal and plant care activity. What’s unique about Envera is its experience in the isolation, selection, production and formulation of microbial cultures.”

Michael L. Matheny, President of Envera comments: “I am delighted to have partnered with Lesaffre, a French family-owned company, known and recognized internationally for its expertise and professionalism in fermentation. I am confident the synergies between our companies, coupled with Lesaffre’s resources and connections around the world, will enable Envera to significantly accelerate its growth.”

By Elizabeth Green